FilingReader Intelligence

Winning Health sees limited conversion of convertible bonds in Q3

October 9, 2025 at 08:41 AM UTCBy FilingReader AI

In the third quarter of 2025, Winning Health Technology Group's convertible bonds saw 291 bonds converted into 1,679 company shares, reducing the bond’s face value by 29,100 yuan. As of September 30, 2025, 9,699,192 bonds remained outstanding, with an unconverted ratio of 99.9644%. The current conversion price is 17.31 yuan per share.

The company's total share capital increased by 1,933,538 shares during the third quarter of 2025, rising from 2,212,684,146 shares on June 30, 2025, to 2,214,617,684 shares on September 30, 2025. This increase primarily stemmed from the exercise of equity incentive options, contributing 1,931,859 shares, with convertible bond conversions adding the remaining 1,679 shares.

The initial conversion price of the Winning Health Convertible Bonds was 17.76 yuan per share, which has been adjusted multiple times due to equity distributions, share repurchases, and equity incentive option exercises. The most recent adjustment, effective June 4, 2025, set the conversion price at 17.31 yuan per share. The conversion period began on September 22, 2021, and is scheduled to conclude on March 15, 2027.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Winning Health Technology Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →